DAVITA INC. (DVA): debt financing — DaVita adds $500M senior secured term loan B facility via Ninth Amendment

DAVITA INC.

Incremental Tranche B-2 Term Loans of $500M added to existing credit agreement; maturity May 2031.
Interest at Term SOFR + 175 bps or Base Rate + 75 bps, at borrower's option.
Proceeds used to repay a portion of outstanding revolving loans, pay fees, and for general corporate purposes.
JPMorgan acts as administrative agent; nine lenders participated as joint lead arrangers.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

DAVITA INC. incurred term loan of $500 million with JPMorgan Chase Bank, N.A., as administrative agent, collateral agent and swingline lender at either the Base Rate plus the Applicable Margin or Term SOFR plus the Applicable maturing May 2031.

Instrument: term loan
Principal: $500 million
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent, collateral agent and swingline lender
Rate: either the Base Rate plus the Applicable Margin or Term SOFR plus the Applicable
Maturity: May 2031
Event: incurrence

Exact text from the filing

The Ninth Amendment, among other things, provides for an incremental borrowing under the Company's existing senior secured term loan "B" facility maturing in May 2031 (the "Tranche B-2 Term Facility" and the loans borrowed thereunder, the "Tranche B-2 Term Loans") in an aggregate principal amount of $500 million (the "Incremental Tranche B-2 Term Loans").

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DAVITA INC. amended Ninth Amendment with JPMorgan Chase Bank, N.A., as administrative agent, collateral agent and swingline lender valued at $500 million (effective 2026-06-08).

Action: amendment
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent, collateral agent and swingline lender
Value: $500 million
Effective: 2026-06-08

Exact text from the filing

The Ninth Amendment, among other things, provides for an incremental borrowing under the Company’s existing senior secured term loan “B” facility maturing in May 2031 (the “Tranche B-2 Term Facility” and the loans borrowed thereunder, the “Tranche B-2 Term Loans”) in an aggregate principal amount of $500 million

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

DAVITA INC. shareholders approved Advisory vote to approve named executive officer compensation at the 2026-06-04 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The voting results are as follows: For Against Abstain Broker Non-Vote 51,716,491 776,849 58,589 7,313,973

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

DAVITA INC. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results are as follows: For Against Abstain 58,286,637 1,534,241 45,024

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

DAVITA INC. shareholders approved Election of the nine director nominees named below to the Company's Board of Directors for a term expiring at the 2027 Annual Meeting at the 2026-06-04 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

The Company’s stockholders elected the nine director nominees named below to the Company’s Board of Directors for a term expiring at the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified. The voting results are as follows: For Against Abstain Broker Non-Vote Pamela M. Arway 51,833,209 700,475 18,245 7,313,973 Barbara J. Desoer 52,223,785 311,047 17,097 7,313,973 Jason M. Hollar 52,234,585 299,851 17,493 7,313,973 Gregory J. Moore, MD, PhD 52,463,031 71,921 16,977 7,313,973 Dennis W. Pullin 52,460,686 54,311 36,932 7,313,973 Javier J. Rodriguez 52,490,301 43,860 17,768 7,313,973 Adam H. Schechter 52,355,165 179,111 17,653 7,313,973 Wendy L. Schoppert 52,449,019 86,452 16,458 7,313,973 Phyllis R. Yale 52,227,836 306,964 17,129 7,313,973

View on SEC.gov

289 debt financings filed in the last 30 days. Browse all debt financings →

DAVITA INC. filing history →

Source: SEC EDGAR

accession 0001206774-26-000316

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.